Xiao Fenglai, Koepp Matthias J, Zhou Dong
Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, United Kingdom.
Front Neurol. 2019 Nov 13;10:1203. doi: 10.3389/fneur.2019.01203. eCollection 2019.
Pharmacological treatment with antiepileptic medications (AEDs) in epilepsy is associated with a variety of neurocognitive side effects. However, the mechanisms underlying these side effects, and why certain brain anatomies are more affected still remain poorly understood. Advanced functional magnetic resonance imaging (fMRI) methods, such as pharmaco-fMRI, can investigate medication-related effects on brain activities using task and resting state fMRI and showing reproducible activation and deactivation patterns. This methodological approach has been used successfully to complement neuropsychological studies of AEDs. Here we review pharmaco-fMRI studies in people with epilepsy targeting the most-widely prescribed AEDs. Pharmco-fMRI has advanced our understanding of the impact of AEDs on specific brain networks and thus may provide potential biomarkers to move beyond the current "trial and error" approach when commencing anti-epileptic medication.
癫痫患者使用抗癫痫药物(AEDs)进行药物治疗会伴随各种神经认知方面的副作用。然而,这些副作用背后的机制,以及为何某些脑区更容易受到影响,目前仍知之甚少。先进的功能磁共振成像(fMRI)方法,如药物功能磁共振成像,可以利用任务态和静息态fMRI研究药物对脑活动的影响,并显示出可重复的激活和失活模式。这种方法已成功用于补充AEDs的神经心理学研究。在此,我们回顾针对最常用AEDs的癫痫患者的药物功能磁共振成像研究。药物功能磁共振成像增进了我们对AEDs对特定脑网络影响的理解,因此在开始抗癫痫药物治疗时,可能提供潜在的生物标志物,以超越当前的“试错”方法。